A randomly selected population sample undergoing colonoscopy: Prevalence of the irritable bowel syndrome and the impact of selection factors

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 3, 2014, Pages 268-275

  Kjellström, Lars ^a,b   Molinder, Herdis ^a   Agréus, Lars ^a   Nyhlin, Henry ^a   Talley, Nicholas J ^d   Andreasson, Anna ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Sabbatsberg Hospital   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Colonoscopy; Epidemiology; Gastrointestinal symptoms; Irritable bowel syndrome; Population based study

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; COLONOSCOPY; FEMALE; HEALTH SURVEYS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PATIENT SELECTION; PREVALENCE; QUESTIONNAIRES; SELECTION BIAS; SEX DISTRIBUTION; SWEDEN; YOUNG ADULT;

EID: 84895073182     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000024     Document Type: Article

References (46)

1. Agréus L. The epidemiology of functional gastrointestinal disorders. Eur J Surg Suppl 1998; 583: 60-66.
2. Cremonini F, Talley N. Irritable bowel syndrome; epidemiology, natural history, health care seeking behaviour and emerging factors. Gastroenterol Clin North Am 2005; 34: 189-204.
3. Kennedy T, Jones R, Hungin A, Kelly P. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998; 43: 770-774.
4. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut 1997; 41: 394-398.
5. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10:712.e4-721.e4.
6. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 2008; 57: 1354-1359.
7. Li Z, Zou D, Ma X, Chen J, Sji X, Gong Y, et al. Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China. Am J Gastroenterol 2010; 105: 2570-2577.
8. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson S, et al. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol 2004; 39: 1280-1288.
9. Agréus L. Socio-economic factors, health care consumption and rating of abdominal symptom severity. A report from The Abdominal Symptom Study. Fam Pract 1993; 10: 152-163.
10. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989; 39: 495-498.
11. Dhaliwal S, Hunt R. Doctor-patient interaction for irritable bowel syndrome in primary care: a systematic perspective. Eur J Gastroenterol Hepatol 2004; 16: 1161-1166.
12. Cheng C. Seeking medical consultation: perceptual and behavioral characteristics distinguishing consulters and nonconsulters with functional dyspepsia. Psychosom Med 2000; 62: 844-852.
13. Ålander T, Svärdsudd K, Johansson S, Agréus L. Psychological illness is commonly associated with functional gastrointestinal disorders and is important to consider during patient consultation: a population-based study. BMC Med 2005; 3:8.
14. Ringström G, Abrahamsson H, Strid H, Simrén M. Why do subjects with irritable bowel syndrome seek health care for their symptoms? Scand J Gastroenterol 2007; 42: 1194-1203.
15. Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol 2008; 103: 1229-1239.
16. Thompson W. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46: 78-82.
17. Hyams JS, Burke G, Davis PM, Rzepski B, Andrulonis PA. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr 1996; 129: 220-226.
18. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care 1993; 11: 252-262.
19. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69: 1035S-1045S.
20. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002; 68: 219-226.
21. Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr 2003; 91: 48-55.
22. Talley NJ, Fodor AA. Bugs, stool, and the irritable bowel syndrome: too much is as bad as too little? Gastroenterology 2011; 141: 1555-1559.
23. Agréus L. The abdominal symptom study. An epidemiological survey of gastrointestinal and other abdominal symptoms in the adult population of Östhammar, Sweden. Uppsala: University of Uppsala; 1993.
24. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 671-680.
25. Drossman DARome II. The functional gastrointestinal disorders. 2nd ed. McLean, VA: Degnon Associates; 2000. pp. 899-915.
26. Agréus L, Talley NJ, Svärdsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort, and bowel habit descriptors. Scand J Gastroenterol 2000; 35: 142-151.
27. Drossman DARome III. The functional gastrointestinal disorders. 3rd ed. McLean, VA: Degnon Associates Inc.; 2006. pp. 899-915.
28. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925-926.
29. Agréus L, Svärdsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001; 96: 2905-2914.
30. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129: 1825-1831.
31. Agréus L. Rome? Manning? Who cares? Am J Gastroenterol 2000; 95: 2679-2681.
32. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001; 36: 1155-1161.
33. Mearin F, Roset M, Badia X, Balboa A, Baro E, Ponce J, et al. Splitting irritable bowel syndrome: from original Rome to Rome II criteria. Am J Gastroenterol 2004; 99: 122-130.
34. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47: 225-235.
35. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 2816-2824.
36. Hillila MT, Farkkila MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004; 20: 339-345.
37. Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005; 21: 1365-1375.
38. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003; 17: 643-650.
39. Muller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 2001; 64: 200-204.
40. Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 991-1000.
41. Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther 2010; 32: 738-755.
42. Thorn M, Sjoberg D, Ekbom A, Holmstrom T, Larsson M, Nielsen AL, et al. Microscopic colitis in Uppsala health region, a population-based prospective study 2005-2009. Scand J Gastroenterol 2013; 48: 825-830.
43. Bolling-Sternevald E, Aro P, Ronkainen J, Storskrubb T, Talley NJ, Junghard O, et al. Do gastrointestinal symptoms fluctuate in the short-tims perspective? The Kalixanda study. Dig Dis 2008; 26: 256-263.
44. Kim DH, Lee SY, Choi KS, Lee HJ, Park SC, Kim J, et al. The usefulness of colonoscopy as a screening test for detecting coloractal polyps. Hepatogastroenterology 2007; 80: 2240-2242.
45. Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH. Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years. Gut 1999; 45: 834-839.
46. Nelson DB, McQuaid KR, Bond JH, Lieberman DA,Weiss DG, Johnston TK. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002; 55:307-314.